Arnuity ellipta and Digoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Arnuity ellipta and Digoxin. Common interactions include erythema among females and abdominal pain upper among males.

The phase IV clinical study analyzes what interactions people who take Arnuity ellipta and Digoxin have. It is created by eHealthMe based on reports of 13 people who take Arnuity ellipta and Digoxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 06, 2023

13 people who take Arnuity ellipta and Digoxin together, and have interactions are studied.

What is Arnuity ellipta?

Arnuity ellipta has active ingredients of fluticasone furoate. eHealthMe is studying from 2,725 Arnuity ellipta users for its effectiveness, alternative drugs and more.

What is Digoxin?

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 89,193 Digoxin users for its effectiveness, alternative drugs and more.

Number of Arnuity ellipta and Digoxin reports submitted per year:

Common Arnuity Ellipta and Digoxin drug interactions by gender *:

female:

Erythema
Nasopharyngitis
Pneumonia
Rash
Rib fracture
Swelling face
Blood glucose decreased
Dysgeusia

male:

Abdominal pain upper
Drug ineffective
Dyspnoea
Death
Rash
Rash pruritic
Respiratory failure
Weight decreased

Common Arnuity Ellipta and Digoxin drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Blood glucose decreased
Death
Dysgeusia
Erythema
Nasopharyngitis
Pneumonia
Rash
Rash pruritic
Rib fracture
Swelling face

Common conditions people have *:

Breathing Difficulty: 2 people, 15.38%
Asthma: 2 people, 15.38%
Thyroid Diseases: 1 person, 7.69%
Pneumonia: 1 person, 7.69%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.69%
Hypersensitivity: 1 person, 7.69%
High Blood Pressure: 1 person, 7.69%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 7.69%
Breast Cancer Female: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Arnuity ellipta and Digoxin?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .